KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Non-Current Assets (2016 - 2025)

Eli Lilly's Other Non-Current Assets history spans 17 years, with the latest figure at $7.0 billion for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 22.24% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $7.0 billion, up 22.24%, while the annual FY2025 figure was $7.0 billion, 22.24% up from the prior year.
  • Other Non-Current Assets reached $7.0 billion in Q4 2025 per LLY's latest filing, up from $6.4 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $7.0 billion in Q4 2025 to a low of $3.6 billion in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $4.9 billion, with a median of $4.7 billion recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: increased 4.27% in 2024, then grew 29.03% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $4.1 billion in 2021, then rose by 6.23% to $4.3 billion in 2022, then rose by 15.05% to $5.0 billion in 2023, then grew by 14.63% to $5.7 billion in 2024, then rose by 22.24% to $7.0 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Other Non-Current Assets are $7.0 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.2 billion (Q2 2025).